The Vaccines for Children (VFC) program was created by the Omnibus Budget Reconciliation Act of 1993 and first implemented in 1994. VFC was designed to ensure that eligible children do not contract vaccine-preventable diseases because of inability to pay for vaccine and was created in response to a measles resurgence in the United States that resulted in approximately 55,000 cases reported during 1989-1991. The resurgence was caused largely by widespread failure to vaccinate uninsured children at the recommended age of 12-15 months. To summarize the impact of the U.S. immunization program on the health of all children (both VFC-eligible and not VFC-eligible) who were born during the 20 years since VFC began, CDC used information on immunization coverage from the National Immunization Survey (NIS) and a previously published cost-benefit model to estimate illnesses, hospitalizations, and premature deaths prevented and costs saved by routine childhood vaccination during 1994-2013. Coverage for many childhood vaccine series was near or above 90% for much of the period. Modeling estimated that, among children born during 1994- 2013, vaccination will prevent an estimated 322 million illnesses, 21 million hospitalizations, and 732,000 deaths over the course of their lifetimes, at a net savings of $295 billion in direct costs and $1.38 trillion in total societal costs. With support from the VFC program, immunization has been a highly effective tool for improving the health of U.S. children.
[1]
L. Wang,et al.
Economic Evaluation of the Routine Childhood Immunization Program in the United States, 2009
,
2014,
Pediatrics.
[2]
Shawn T. Brown,et al.
Contagious diseases in the United States from 1888 to the present.
,
2013,
The New England journal of medicine.
[3]
M. Kolasa,et al.
National, State, and Local Area Vaccination Coverage Among Children Aged 19–35 Months — United States, 2012
,
2013,
MMWR. Morbidity and mortality weekly report.
[4]
Carrie Reed,et al.
Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005–2011
,
2013,
PloS one.
[5]
A. Schuchat,et al.
Vaccine-preventable diseases, immunizations, and MMWR--1961-2011.
,
2011,
MMWR supplements.
[6]
S. Pelton,et al.
Cost-effectiveness of pneumococcal conjugate vaccine: an update after 7 years of use in the United States.
,
2009,
Vaccine.
[7]
T. Murphy,et al.
Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States.
,
2007,
JAMA.
[8]
W. Orenstein.
The Role of Measles Elimination in Development of a National Immunization Program
,
2006,
The Pediatric infectious disease journal.